Amneal Pharmaceuticals Inc (AMRX)
8.19
-0.16
(-1.92%)
USD |
NASDAQ |
Sep 27, 16:00
8.19
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Accounts Receivable (Quarterly): 769.87M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 769.87M |
March 31, 2024 | 668.96M |
December 31, 2023 | 613.73M |
September 30, 2023 | 690.95M |
June 30, 2023 | 674.74M |
March 31, 2023 | 545.76M |
December 31, 2022 | 741.79M |
September 30, 2022 | 628.74M |
June 30, 2022 | 688.85M |
March 31, 2022 | 538.31M |
December 31, 2021 | 662.58M |
September 30, 2021 | 627.95M |
June 30, 2021 | 652.02M |
Date | Value |
---|---|
March 31, 2021 | 530.60M |
December 31, 2020 | 638.90M |
September 30, 2020 | 707.10M |
June 30, 2020 | 582.73M |
March 31, 2020 | 722.68M |
December 31, 2019 | 604.39M |
September 30, 2019 | 518.11M |
June 30, 2019 | 634.67M |
March 31, 2019 | 640.21M |
December 31, 2018 | 481.50M |
September 30, 2018 | 641.03M |
June 30, 2018 | 626.49M |
December 31, 2017 | 351.37M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
518.11M
Minimum
Sep 2019
769.87M
Maximum
Jun 2024
640.44M
Average
645.46M
Median
Accounts Receivable (Quarterly) Benchmarks
Eli Lilly and Co | 11.03B |
Amphastar Pharmaceuticals Inc | 131.41M |
Nutriband Inc | 0.068M |
NovaBay Pharmaceuticals Inc | 0.547M |
Palatin Technologies Inc | 0.00 |